Pet Imaging and its Application in Cardiovascular Diseases

Zheng Li; Anisha A. Gupte; Aijun Zhang; Dale J. Hamilton

doi:10.14797/mdcj-13-1-29

Pet Imaging and its Application in Cardiovascular Diseases

Zheng Li, Anisha A. Gupte, Aijun Zhang, Dale J. Hamilton

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide and represent a great challenge for modern research and medicine. Despite advances in preventing and treating CVD over the decades, there remains an urgent need to develop sensitive and safe methods for early detection and personalized treatment. With refinements of molecular imaging technologies such as positron emission tomography (PET), noninvasive imaging of CVDs is experiencing impressive progress in both preclinical and clinical settings. In this review, we summarize advances in cardiovascular PET imaging, highlight the latest development of CVD imaging probes, and illustrate the potential for individualized therapy based on metabolic phenotype.

Original language	English (US)
Pages (from-to)	29-33
Number of pages	5
Journal	Methodist DeBakey cardiovascular journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.14797/mdcj-13-1-29
State	Published - Mar 1 2017

Keywords

heart failure
metabolic imaging
personalized therapy
PET imaging

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.14797/mdcj-13-1-29

Cite this

@article{65e90436fcfa4b7da1e9bd230f19508a,

title = "Pet Imaging and its Application in Cardiovascular Diseases",

abstract = "Cardiovascular diseases (CVDs) are the leading cause of death worldwide and represent a great challenge for modern research and medicine. Despite advances in preventing and treating CVD over the decades, there remains an urgent need to develop sensitive and safe methods for early detection and personalized treatment. With refinements of molecular imaging technologies such as positron emission tomography (PET), noninvasive imaging of CVDs is experiencing impressive progress in both preclinical and clinical settings. In this review, we summarize advances in cardiovascular PET imaging, highlight the latest development of CVD imaging probes, and illustrate the potential for individualized therapy based on metabolic phenotype.",

keywords = "heart failure, metabolic imaging, personalized therapy, PET imaging",

author = "Zheng Li and Gupte, {Anisha A.} and Aijun Zhang and Hamilton, {Dale J.}",

year = "2017",

month = mar,

day = "1",

doi = "10.14797/mdcj-13-1-29",

language = "English (US)",

volume = "13",

pages = "29--33",

journal = "Methodist DeBakey cardiovascular journal",

issn = "1947-6094",

publisher = "Methodist DeBakey Heart & Vascular Center",

number = "1",

}

TY - JOUR

T1 - Pet Imaging and its Application in Cardiovascular Diseases

AU - Li, Zheng

AU - Gupte, Anisha A.

AU - Zhang, Aijun

AU - Hamilton, Dale J.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Cardiovascular diseases (CVDs) are the leading cause of death worldwide and represent a great challenge for modern research and medicine. Despite advances in preventing and treating CVD over the decades, there remains an urgent need to develop sensitive and safe methods for early detection and personalized treatment. With refinements of molecular imaging technologies such as positron emission tomography (PET), noninvasive imaging of CVDs is experiencing impressive progress in both preclinical and clinical settings. In this review, we summarize advances in cardiovascular PET imaging, highlight the latest development of CVD imaging probes, and illustrate the potential for individualized therapy based on metabolic phenotype.

AB - Cardiovascular diseases (CVDs) are the leading cause of death worldwide and represent a great challenge for modern research and medicine. Despite advances in preventing and treating CVD over the decades, there remains an urgent need to develop sensitive and safe methods for early detection and personalized treatment. With refinements of molecular imaging technologies such as positron emission tomography (PET), noninvasive imaging of CVDs is experiencing impressive progress in both preclinical and clinical settings. In this review, we summarize advances in cardiovascular PET imaging, highlight the latest development of CVD imaging probes, and illustrate the potential for individualized therapy based on metabolic phenotype.

KW - heart failure

KW - metabolic imaging

KW - personalized therapy

KW - PET imaging

UR - http://www.scopus.com/inward/record.url?scp=85029708433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029708433&partnerID=8YFLogxK

U2 - 10.14797/mdcj-13-1-29

DO - 10.14797/mdcj-13-1-29

M3 - Review article

C2 - 28413580

SN - 1947-6094

VL - 13

SP - 29

EP - 33

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

IS - 1

ER -

Pet Imaging and its Application in Cardiovascular Diseases

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this